Status:
UNKNOWN
The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
Lead Sponsor:
Assiut University
Conditions:
Beta-Thalassemia
Eligibility:
All Genders
Brief Summary
1. \- To design an amplification-refractory mutation system (ARMS) for the DNA diagnosis of the IVS I-6 (T\>C) mutation. 2. \- To detect the prevelence of the mutation among Assiut University Hospital...
Detailed Description
• The β-thalassaemias result from 300 gene mutations ( https://globin.bx.psu.edu ). All of the mutations are regionally specific and the spectrum of mutations has now been determined for most at-risk...
Eligibility Criteria
Inclusion
- : β thalassemia (suspected \& clinically diagnosed cases).
Exclusion
- : Iron deficiency anaemia, anaemia of chronic disease, types of haemolytic anaemias other than thalassemia, other types of thalassemia and Hb variants
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT05370677
Start Date
May 1 2022
End Date
December 1 2024
Last Update
May 11 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.